Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia

Tundra lists 1 Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT03932331

Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

This is an open-label, two-part study to assess the safety, tolerability, pharmacokinetics and clinical efficacy of acalabrutinib in Chinese adult subjects with R/R MCL, CLL and other B-cell malignancies. The study is divided into 2 parts: Phase 1 portion and Phase 2 portion.

Gender: All

Ages: 18 Years - 130 Years

Updated: 2026-01-29

Phase I: Relapsed or Refractory B-cell Malignancies

Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma

Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia